Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000914190-21-000166

Pres. Diagnostics & Genom sold 845 shares at $424.00 ($358,280)

From the SEC's structured data for this filing

Trades in this filing

Kelderman Kim · Pres. Diagnostics & Genom

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-05-25 Sale : show line 1 in the form −845 $424.00 $358,280 811 D
Open-market sales · 845 sh · avg $424.00 · $358,280
Loading xslF345X03/edgar.xml…